Patent · US Active

Progesterone receptor antagonists

US9109004B2 · kind B2 · utility

1Cited by

32References

10Claims

0Family size

Assignee

Bayer Intellectual Property GmbH · DE

Inventors

Wolfgang Schwede · Berlin, DE
Ulrich Klar · Berlin, DE
Carsten Möller · Berlin, DE
Andrea Rotgeri · Berlin, DE
Wilhelm Bone · Berlin, DE
Christoph Huwe · Berlin, DE

Key dates

Filing date	Feb 8, 2011
Grant date	Aug 18, 2015
Priority date	—
Expiry date	Nov 20, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/58
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives of formula I with progesterone-antagonizing action and methods of production thereof, use thereof for the treatment and/or prevention of diseases and use thereof for producing medicinal products for the treatment and/or prevention of diseases, in particular uterine fibroids (myomata, uterine leiomyomata), endometriosis, heavy menstrual bleeding, meningiomata, hormone-dependent breast cancers and menopause-associated complaints or for fertility control and emergency contraception.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.